Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2021

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview

• 1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
• 1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
  • 1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Radiopharmaceuticals
  • 1.2.3 Contrast Media
• 1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
  • 1.3.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
  • 1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2016-2027
  • 1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2016-2027
  • 1.4.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers

• 2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites, Area Served, Product Type
• 2.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
  • 2.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
  • 2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region

• 3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
  • 3.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
  • 3.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
  • 3.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
  • 3.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
  • 3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
  • 3.6.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
  • 3.6.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
  • 3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Type

• 4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2021)
• 4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2016-2021)
• 4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2021)

5 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Application

• 5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2021)
• 5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2016-2021)
• 5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Amag Pharmaceuticals
  • 6.1.1 Amag Pharmaceuticals Corporation Information
  • 6.1.2 Amag Pharmaceuticals Description and Business Overview
  • 6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Amag Pharmaceuticals Product Portfolio
  • 6.1.5 Amag Pharmaceuticals Recent Developments/Updates
• 6.2 Bayer Healthcare
  • 6.2.1 Bayer Healthcare Corporation Information
  • 6.2.2 Bayer Healthcare Description and Business Overview
  • 6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bayer Healthcare Product Portfolio
  • 6.2.5 Bayer Healthcare Recent Developments/Updates
• 6.3 Bracco Imaging
  • 6.3.1 Bracco Imaging Corporation Information
  • 6.3.2 Bracco Imaging Description and Business Overview
  • 6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bracco Imaging Product Portfolio
  • 6.3.5 Bracco Imaging Recent Developments/Updates
• 6.4 Daiichi Sankyo
  • 6.4.1 Daiichi Sankyo Corporation Information
  • 6.4.2 Daiichi Sankyo Description and Business Overview
  • 6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Daiichi Sankyo Product Portfolio
  • 6.4.5 Daiichi Sankyo Recent Developments/Updates
• 6.5 GE Healthcare
  • 6.5.1 GE Healthcare Corporation Information
  • 6.5.2 GE Healthcare Description and Business Overview
  • 6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 GE Healthcare Product Portfolio
  • 6.5.5 GE Healthcare Recent Developments/Updates
• 6.6 Guerbet
  • 6.6.1 Guerbet Corporation Information
  • 6.6.2 Guerbet Description and Business Overview
  • 6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Guerbet Product Portfolio
  • 6.6.5 Guerbet Recent Developments/Updates
• 6.7 Lantheus
  • 6.6.1 Lantheus Corporation Information
  • 6.6.2 Lantheus Description and Business Overview
  • 6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Lantheus Product Portfolio
  • 6.7.5 Lantheus Recent Developments/Updates
• 6.8 Mallinckrodt
  • 6.8.1 Mallinckrodt Corporation Information
  • 6.8.2 Mallinckrodt Description and Business Overview
  • 6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mallinckrodt Product Portfolio
  • 6.8.5 Mallinckrodt Recent Developments/Updates
• 6.9 Medtronic
  • 6.9.1 Medtronic Corporation Information
  • 6.9.2 Medtronic Description and Business Overview
  • 6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Medtronic Product Portfolio
  • 6.9.5 Medtronic Recent Developments/Updates
• 6.10 Nordion
  • 6.10.1 Nordion Corporation Information
  • 6.10.2 Nordion Description and Business Overview
  • 6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Nordion Product Portfolio
  • 6.10.5 Nordion Recent Developments/Updates

7 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Cost Analysis

• 7.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
• 7.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
• 8.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers

9 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics

• 9.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
• 9.2 Diagnostic Radiopharmaceuticals & Contrast Media Growth Drivers
• 9.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
• 9.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

10 Global Market Forecast

• 10.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2022-2027)
• 10.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2022-2027)
• 10.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List